AI assistant
Century Therapeutics, Inc. — Director's Dealing 2024
Jun 6, 2024
34658_dirs_2024-06-06_8c2ef557-5d48-43f8-a09b-24cb85290c7b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Century Therapeutics, Inc. (IPSC)
CIK: 0001850119
Period of Report: 2024-06-05
Reporting Person: Russotti Gregory (See Remarks)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-06-05 | Common Stock | S | 5000 | $2.9978 | Disposed | 282319 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 92773 | Indirect |
Footnotes
F1: The transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 9, 2024.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.895 to $3.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.